Displaying items by tag: department of medicine

UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
Study published in the American Journal of Gastroenterology shows fecal incontinence risk from anal intercourse is heightened for both women and men, with men almost three times as likely to experience incontinence.
UAB’s Landefeld named to government panel that helps determine recommendations on preventive health measures.
The Sickle Cell Foundation has completed a $1 million gift to the UAB Adult Sickle Cell Clinic.

A new eight-week FreshStart! program is set for Jan. 21-March 10 to help cancer survivors make healthy lifestyle changes.

UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
North Carolina resident Jerry Phillips has known since 2001 that he would one day need a kidney transplant. Fourteen years later, his need was fulfilled by a stranger and his transplant surgery performed by a friend.
Best of 2015 2Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD.
UAB is using an online survey to learn more about the relationship between diet and gout.
UAB leads a team that crafts new American College of Rheumatology guidelines for 2015 on treatment of rheumatoid arthritis.
Treating patients 50 and older with high blood pressure to a systolic blood pressure of less than 120 mm Hg reduced rates of cardiovascular events, including heart attack, heart failure and stroke, by 25 percent.
Page 30 of 36